Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaia Moretta

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Dermatology : EJD|July 13, 2017
Linear IgA bullous dermatosis in a two-year-old child: possible association with aspirinAntonio Gatto, Cristina Guerriero, Gaia Moretta, et al.
International Journal of Molecular Sciences|March 10, 2022
Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic TargetsLuca Fania, Gaia Moretta, Flaminia Antonelli, et al.
Drug Development Research|November 11, 2014
A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasisClara De Simone, Giacomo Caldarola, Marialuisa Corbeddu, et al.
Pharmacogenetics and Genomics|June 28, 2016
HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patientsGiacomo Caldarola, Alessandro Sgambato, Caterina Fanali, et al.
Discover Oncology|February 24, 2022
Attitudes among dermatologists regarding non-melanoma skin cancer treatment optionsLuca Fania, Tonia Samela, Gaia Moretta, et al.
Dermatologic Therapy|September 29, 2022
Cutaneous Rosai-Dorfman disease after Covid 19 vaccination treated with thalidomideMarta Grimaldi, Francesca Perino, Gaia Moretta, et al.
European Journal of Dermatology : EJD|April 12, 2019
Prevalence of cutaneous comorbidities in psoriatic patients and their impact on quality of lifeGiacomo Caldarola, Clara De Simone, Marina Talamonti, et al.
Drugs in Context|April 20, 2023
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experienceGiacomo Caldarola, Arianna Zangrilli, Gerardo Palmisano, et al.
International Journal of Dermatology|December 2, 2025
Unmasking the High Prevalence of Psychological Morbidity in Atopic Dermatitis-A Call for Routine ScreeningAnna Dattolo, Damiano Abeni, Barbara Cocuroccia, et al.
Expert Opinion on Biological Therapy|May 26, 2018
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observationMarco Galluzzo, Marina Talamonti, Clara De Simone, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Dermatology : EJD|July 13, 2017
Linear IgA bullous dermatosis in a two-year-old child: possible association with aspirinAntonio Gatto, Cristina Guerriero, Gaia Moretta, et al.
International Journal of Molecular Sciences|March 10, 2022
Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic TargetsLuca Fania, Gaia Moretta, Flaminia Antonelli, et al.
Drug Development Research|November 11, 2014
A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasisClara De Simone, Giacomo Caldarola, Marialuisa Corbeddu, et al.
Pharmacogenetics and Genomics|June 28, 2016
HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patientsGiacomo Caldarola, Alessandro Sgambato, Caterina Fanali, et al.
Discover Oncology|February 24, 2022
Attitudes among dermatologists regarding non-melanoma skin cancer treatment optionsLuca Fania, Tonia Samela, Gaia Moretta, et al.
Dermatologic Therapy|September 29, 2022
Cutaneous Rosai-Dorfman disease after Covid 19 vaccination treated with thalidomideMarta Grimaldi, Francesca Perino, Gaia Moretta, et al.
European Journal of Dermatology : EJD|April 12, 2019
Prevalence of cutaneous comorbidities in psoriatic patients and their impact on quality of lifeGiacomo Caldarola, Clara De Simone, Marina Talamonti, et al.
Drugs in Context|April 20, 2023
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experienceGiacomo Caldarola, Arianna Zangrilli, Gerardo Palmisano, et al.
International Journal of Dermatology|December 2, 2025
Unmasking the High Prevalence of Psychological Morbidity in Atopic Dermatitis-A Call for Routine ScreeningAnna Dattolo, Damiano Abeni, Barbara Cocuroccia, et al.
Expert Opinion on Biological Therapy|May 26, 2018
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observationMarco Galluzzo, Marina Talamonti, Clara De Simone, et al.
Pageof 6